Pathway analysis demonstrated that PI3K‐Akt was the most activated pathway in patients with pancreatic ITPN; the statistical associations considering all cancer types, based on the pathway analysis, were more significant in breast and hepatocellular cancers than in conventional pancreatic cancer (Figure S2). This evidence concerns the gene AKT1 and familial pancreatic carcinoma.